SCHEMBL6966640

SCHEMBL6966640

[CH2]CCOc1ccccc1[N+](=O)[O-]

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.79
RAB9A P51151 4/20 0.79
RECQL P46063 2/20 0.79
ALDH1A1 P00352 8/20 0.60
KMT2A Q03164 3/20 0.60
LMNA P02545 2/20 0.60
SMN1; SMN2 Q16637 2/20 0.60
KDM4E B2RXH2 4/20 0.56
MAPT P10636 3/20 0.56
MEN1 O00255 2/20 0.56
MAPK1 P28482 1/20 0.56
TDP1 Q9NUW8 1/20 0.55
HTT P42858 1/20 0.54
CYP1A2 P05177 1/20 0.54
CYP2D6 P10635 1/20 0.54
CYP2C19 P33261 1/20 0.54
POLB P06746 1/20 0.52
KCNH2 Q12809 1/20 0.52
HPGD P15428 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3032330 0.91 NPC1 (0.77) NPC1RAB9ARECQLALDH1A1KMT2A
SCHEMBL7476786 0.90 NPC1 (0.74) NPC1RAB9ARECQLALDH1A1KMT2A
SCHEMBL9187561 0.89 NPC1 (1.00) NPC1RAB9ARECQLALDH1A1KMT2A
SCHEMBL8778559 0.88 NPC1 (0.72) NPC1RAB9ARECQLALDH1A1KMT2A
SCHEMBL9642715 0.87 NPC1 (0.89) NPC1RAB9ARECQLALDH1A1KMT2A
SCHEMBL535559 0.85 RAB9A (0.72) NPC1RAB9ARECQLALDH1A1KMT2A
SCHEMBL13435257 0.84 NPC1 (0.89) NPC1RAB9ARECQLALDH1A1KMT2A
SCHEMBL13531827 0.84 NPC1 (0.89) NPC1RAB9ARECQLALDH1A1KMT2A
SCHEMBL29905043 0.82 NPC1 (0.79) NPC1RAB9ARECQLALDH1A1KMT2A
SCHEMBL29707208 0.82 NPC1 (0.79) NPC1RAB9ARECQLALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5639741-A STEROIDS TREATING SKIN DISORDERS MERCK & CO., INC. (US) 1997-06-17 US claimed
EP-0649431-A4 17-AMINO SUBSTITUTED 4-AZASTEROID 5-G(A)-REDUCTASE INHIBITORS. 1995-05-03 EP claimed
EP-0649431-A1 17-AMINO SUBSTITUTED 4-AZASTEROID 5$g(a)-REDUCTASE INHIBITORS MERCK & CO. INC. (US) 1995-04-26 EP claimed
WO-1993023038-A1 17-AMINO SUBSTITUTED 4-AZASTEROID 5α-REDUCTASE INHIBITORS MERCK & CO., INC. (US) 1993-11-25 WO claimed
CN-102464631-A Piperazine substituted 1,3-disubstitued urea compounds and piperazine substituted amide compounds, preparation method, and use thereof SHANGHAI INST MATERIA MEDICA 2012-05-23 CN disclosed
EP-1329160-A2 4-ACYLAMINOPYRAZOLE DERIVATIVES Sankyo Company, Limited (JP) 2003-07-23 EP disclosed